跳至主要内容
临床试验/NCT04924946
NCT04924946Unknown不适用

Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs

Assistance Publique - Hôpitaux de Paris7 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
7
主要终点
Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings

研究概览

简要总结

Multicenter, prospective and observational study of practices and impacts of the use of antihypertensive therapies in intensive medicine and intensive care

详细描述

Multicenter, prospective observational cohort study on 200 patients, by doctor's questionnaire on the prescription of antihypertensive drugs in intensive care, follow-up over 72 hours of the prescription.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient
  • Admitted to an intensive care unit
  • Patient having presented a state of circulatory shock, defined by the need for continuous administration of a vasopressive amine for at least one hour, among: Noradrenaline, Adrenaline
  • In whom the introduction of drug treatment for antihypertensive purposes is decided

排除标准

  • Patient admitted to intensive care for a hypertensive emergency (hypertensive surge or malignant arterial hypertension leading to organ dysfunction
  • Patient who has already received at least one anti-hypertensive drug during his stay in intensive care
  • Cerebro-injured patient, proven or suspected cerebral edema, head trauma <1 month, decrease in cerebral perfusion measured
  • Proven or suspected active bleeding
  • Patient refusal of participation

结局指标

主要结局

Make an inventory of prescribing habits and detect any differences in efficacy and tolerance of antihypertensive drugs in intensive care and intensive care settings

时间窗: 60 days after inclusion

reasons for prescribers

次要结局

  • Search for efficiency differences between the different molecules(60 days after inclusion)
  • Search for differences in side effects between the different molecules(60 days after inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验